apnea has been researched along with doxapram in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (32.76) | 18.7374 |
1990's | 15 (25.86) | 18.2507 |
2000's | 14 (24.14) | 29.6817 |
2010's | 8 (13.79) | 24.3611 |
2020's | 2 (3.45) | 2.80 |
Authors | Studies |
---|---|
Bairam, A; Faulon, M; Monin, P; Vert, P | 1 |
Brion, LP; Reinersman, G; Roth, P; Vega-Rich, C | 1 |
Irani, AJ; Merchant, RH | 1 |
Coutts, RT; Finer, NN; Jamali, F; Malek, F; Peliowski, A | 1 |
Ruggins, NR | 1 |
Akramoff-Gershan, L; Aranda, JV; Bairam, A; Beharry, K; Laudignon, N; Papageorgiou, A | 1 |
Cates, DB; Hasan, SU; Kwiatkowski, K; Rigatto, H; Seifert, B; Tay-Uyboco, J | 1 |
Finer, NN; Peliowski, A | 1 |
Bairam, A; Vert, P | 1 |
Barrington, KJ; Barton, J; Finer, NN; Peters, KL | 1 |
Barrington, KJ; Coutts, RT; Finer, NN; Jamali, F; Torok-Both, G | 1 |
Clyburn, PA; Rosen, M | 1 |
Barrington, KJ; Coutts, RT; Finer, NN; Jamali, F; Torok-Both, GA | 1 |
Beaudry, MA; Bradley, JM; Gramlich, LM; LeGatt, D | 1 |
Duffty, P; Lloyd, DJ; Rose, SJ | 1 |
Hakamada, S; Hayakawa, F; Kuno, K; Miyachi, Y; Nakashima, T | 1 |
Cater, G; Hall, RT; Shaffer, S | 1 |
Alpan, G; Arad, I; Dgani, Y; Eyal, F; Glick, B; Peleg, O; Sagi, E | 1 |
Musto, P; Orecchia, C; Zocche, GP | 1 |
Stovner, J | 1 |
Gifford, RR; Jacobsen, PM; Plaut, MR | 1 |
Klethi, J; Mack, G; Messer, J; Willard, D | 1 |
Alpan, G; Arad, I; Eyal, F; Patz, D; Sagi, E | 1 |
Dear, PR; Wheeler, D | 1 |
Alpan, G; Eyal, F; Goder, K; Patz, D; Sagi, E; Springer, C | 1 |
Moore, RG; Nichol, H; Thomas, J; Vine, J | 1 |
Nehlig, A | 1 |
Sun, KO | 1 |
Burton, HR; McLean, S; Nicol, S; Slip, DJ; Woods, R | 1 |
De Villiers, GS; Kalis, NN; Van der Merwe, PL; Walele, A | 1 |
Boutroy, MJ; Hascoët, JM | 1 |
Huon, C; Moriette, G; Mussat, P; Parat, S; Rey, E | 1 |
Bohnhorst, B; Darraj, S; Poets, CF | 1 |
Henderson-Smart, DJ; Steer, PA | 2 |
Henderson-Smart, DJ; Steer, P | 2 |
Bhatia, J | 1 |
Boutroy, MJ; Hamon, I; Hascoet, JM | 1 |
Fujimura, M; Itahashi, K; Kajiwara, M; Yamazaki, T | 1 |
Demianczuk, N; Etches, PC; Robertson, CM; Sreenan, C | 1 |
Bhatt-Mehta, V; Schumacher, RE | 1 |
Horsch, S; Roll, C | 1 |
Henderson-Smart, D; Steer, P | 1 |
Gaugler, C; Marlier, L; Messer, J | 1 |
Bénard, M; Boutroy, MJ; Casper, C; Glorieux, I | 1 |
Bertini, G; Dani, C; Filippi, L; Pezzati, M; Pratesi, S; Rubaltelli, FF; Tronchin, M | 1 |
Ferdynus, C; Fischer, C; Gouyon, JB; Semama, DS | 1 |
Berger, A; Czaba-Hnizdo, C; Klebermass-Schrehof, K; Olischar, M; Rona, Z; Weninger, M | 1 |
Irie, T; Irikura, M; Ishitsuka, Y; Kamada, N; Kobaru, Y; Kochiyama, Y; Kondo, Y; Ogawa, Y; Ohno, H; Tomiyasu, M; Uriu, M; Yamazaki, T; Yukawa, E | 1 |
Brouwer, E; Onland, W; Rijken, M; Te Pas, AB; Ten Hove, CH; van Kaam, AH; van Wassenaer-Leemhuis, AG; Vliegenthart, RJ | 1 |
Benard, M; Boutroy, MJ; Casper, C; Greze, E; Haddad, FE; Hamon, I; Hascoët, JM | 1 |
Onland, W; Ten Hove, CH; van Kaam, AH; Vliegenthart, RJ | 1 |
Flint, R; Halbmeijer, N; Meesters, N; Reiss, I; Simons, S; van Dijk, M; van Rosmalen, J | 1 |
de Jongh, FH; de Waal, CG; Hutten, GJ; Kraaijenga, JV; van Kaam, AH | 1 |
Engbers, AGJ; Flint, RB; Knibbe, CAJ; Koch, BCP; Poets, CF; Reiss, IKM; Simons, SHP; Völler, S | 1 |
Avdic, E; Bruschettini, M; Evans, S; Fiander, M; Pessano, S; Soll, R | 1 |
13 review(s) available for apnea and doxapram
Article | Year |
---|---|
Pharmacotherapy of neonatal apnea.
Topics: Apnea; Caffeine; Citrates; Doxapram; Drug Combinations; Humans; Infant, Newborn; Theophylline | 1991 |
Pathophysiology of apnoea in preterm infants.
Topics: Apnea; Doxapram; Humans; Infant, Newborn; Infant, Premature, Diseases; Larynx; Pharynx; Positive-Pressure Respiration; Respiration; Xanthines | 1991 |
Effects of respiratory stimulants on cerebral metabolism and blood flow.
Topics: Adult; Animals; Animals, Newborn; Apnea; Brain; Cerebrovascular Circulation; Doxapram; Energy Metabolism; Humans; Infant, Newborn; Xanthines | 1994 |
Doxapram treatment for apnea in preterm infants.
Topics: Apnea; Doxapram; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Respiratory System Agents | 2000 |
Doxapram versus methylxanthine for apnea in preterm infants.
Topics: Aminophylline; Apnea; Doxapram; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Respiratory System Agents; Theophylline; Xanthines | 2000 |
Current options in the management of apnea of prematurity.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Doxapram; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Theophylline; Xanthines | 2000 |
Doxapram versus methylxanthine for apnea in preterm infants.
Topics: Aminophylline; Apnea; Doxapram; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Randomized Controlled Trials as Topic; Respiratory System Agents; Theophylline; Xanthines | 2000 |
Risks and benefits of therapies for apnoea in premature infants.
Topics: Apnea; Doxapram; Feeding Methods; Humans; Infant, Newborn; Infant, Premature; Positive-Pressure Respiration; Respiratory System Agents; Xanthines | 2000 |
Doxapram treatment for apnea in preterm infants.
Topics: Apnea; Doxapram; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Respiratory System Agents | 2001 |
Treatment of apnea of prematurity.
Topics: Aminophylline; Apnea; Caffeine; Clinical Trials as Topic; Doxapram; Humans; Infant, Newborn; Infant, Premature; Respiratory System Agents; Theophylline | 2003 |
Doxapram treatment for apnea in preterm infants.
Topics: Aminophylline; Apnea; Doxapram; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Respiratory System Agents | 2004 |
Doxapram Treatment for Apnea of Prematurity: A Systematic Review.
Topics: Apnea; Caffeine; Doxapram; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Randomized Controlled Trials as Topic; Respiratory System Agents; Theophylline | 2017 |
Doxapram for the prevention and treatment of apnea in preterm infants.
Topics: Aminophylline; Apnea; Caffeine; Doxapram; Humans; Infant, Newborn; Infant, Premature; Lung Diseases | 2023 |
10 trial(s) available for apnea and doxapram
Article | Year |
---|---|
A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity.
Topics: Apnea; Doxapram; Drug Combinations; Female; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Male; Placebos; Randomized Controlled Trials as Topic; Single-Blind Method; Theophylline | 1990 |
Patient-controlled analgesia with a mixture of pethidine and doxapram hydrochloride. A comparison of the incidence of respiratory dysrhythmias with pethidine alone.
Topics: Adult; Aged; Apnea; Carbon Dioxide; Doxapram; Drug Therapy, Combination; Female; Humans; Male; Meperidine; Middle Aged; Pain, Postoperative; Postoperative Complications; Respiration; Self Administration | 1988 |
Aminophylline versus doxapram in idiopathic apnea of prematurity: a double-blind controlled study.
Topics: Aminophylline; Apnea; Double-Blind Method; Doxapram; Drug Resistance; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature, Diseases | 1985 |
Use of the respiratory stimulant doxapram in southern elephant seals (Mirounga leonina).
Topics: Animals; Apnea; Doxapram; Drug Administration Routes; Female; Intubation; Respiratory System Agents; Restraint, Physical; Seals, Earless; Time Factors; Treatment Outcome | 1996 |
Low-dose doxapram for treatment of apnoea following early weaning in very low birthweight infants: a randomized, double-blind study.
Topics: Apnea; Blood Pressure; Caffeine; Central Nervous System Stimulants; Double-Blind Method; Doxapram; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Infusions, Intravenous; Respiratory System Agents; Treatment Outcome; Ventilator Weaning | 1998 |
Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants.
Topics: Apnea; Birth Weight; Bradycardia; Caffeine; Doxapram; Drug Resistance; Gestational Age; Humans; Hypoxia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infusions, Intravenous; Intubation, Gastrointestinal; Oxygen; Respiratory System Agents | 1999 |
Effect of doxapram on cerebral blood flow velocity in preterm infants.
Topics: Anterior Cerebral Artery; Apnea; Blood Flow Velocity; Cerebrovascular Circulation; Doxapram; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Respiratory System Agents; Ultrasonography | 2004 |
Olfactory stimulation prevents apnea in premature newborns.
Topics: Apnea; Aromatherapy; Bradycardia; Caffeine; Central Nervous System Stimulants; Combined Modality Therapy; Doxapram; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Odorants; Physical Stimulation; Respiratory System Agents; Smell | 2005 |
Population pharmacokinetics of doxapram in low-birth-weight Japanese infants with apnea.
Topics: Apnea; Asian People; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Double-Blind Method; Doxapram; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Japan; Male; Mass Spectrometry; Models, Biological | 2015 |
Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial.
Topics: Apnea; Double-Blind Method; Doxapram; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Prospective Studies; Respiratory System Agents | 2016 |
35 other study(ies) available for apnea and doxapram
Article | Year |
---|---|
Doxapram for the initial treatment of idiopathic apnea of prematurity.
Topics: Apnea; Doxapram; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Respiration; Total Lung Capacity | 1992 |
Low-dose doxapram for apnea unresponsive to aminophylline in very low birthweight infants.
Topics: Aminophylline; Apnea; Benzyl Alcohol; Benzyl Alcohols; Dose-Response Relationship, Drug; Doxapram; Drug Synergism; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Pilot Projects; Positive-Pressure Respiration; Theophylline; Ventilator Weaning | 1991 |
Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity.
Topics: Apnea; Body Weight; Doxapram; Drug Interactions; Female; Gestational Age; Half-Life; Humans; Infant, Newborn; Infant, Premature; Male; Theophylline | 1991 |
Gastrointestinal absorption of doxapram in neonates.
Topics: Administration, Oral; Apnea; Blood Pressure; Dose-Response Relationship, Drug; Doxapram; Female; Humans; Infant, Newborn; Infant, Premature; Intestinal Absorption; Male; Metabolic Clearance Rate | 1991 |
Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity.
Topics: Apnea; Doxapram; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Intubation, Gastrointestinal; Male; Respiratory Function Tests; Theophylline | 1991 |
Low-dose doxapram for apnoea of prematurity.
Topics: Apnea; Caffeine; Doxapram; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature, Diseases; Pilot Projects; Recurrence | 1986 |
Physiologic effects of doxapram in idiopathic apnea of prematurity.
Topics: Aminophylline; Apnea; Birth Weight; Blood Pressure; Carbon Dioxide; Doxapram; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Infusions, Parenteral; Monitoring, Physiologic; Respiration, Artificial; Respiratory Center; Respiratory Function Tests; Time Factors | 1986 |
Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity.
Topics: Apnea; Blood Pressure; Carbon Dioxide; Dose-Response Relationship, Drug; Doxapram; Half-Life; Heart Rate; Humans; Infant, Newborn; Infant, Premature, Diseases; Respiration | 1987 |
Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data.
Topics: Apnea; Doxapram; Drug Administration Schedule; Humans; Infant, Newborn; Infant, Premature, Diseases | 1988 |
Pharmacokinetics of doxapram in idiopathic apnea of prematurity.
Topics: Apnea; Doxapram; Female; Half-Life; Humans; Infant, Newborn; Infant, Premature, Diseases | 1988 |
Doxapram for apnea of prematurity.
Topics: Apnea; Doxapram; Humans; Infant, Newborn; Infant, Premature, Diseases | 1987 |
Doxapram in the treatment of idiopathic apnea of prematurity: desirable dosage and serum concentrations.
Topics: Apnea; Doxapram; Humans; Infant, Newborn; Infant, Premature, Diseases; Infusions, Parenteral | 1986 |
Doxapram for apnea of prematurity.
Topics: Apnea; Doxapram; Humans; Infant, Newborn; Infant, Premature, Diseases | 1986 |
A new analeptic agent: doxapram hydrochloride (Dopram).
Topics: Apnea; Central Nervous System Stimulants; Doxapram; Humans; Postoperative Complications | 1966 |
[Considerations on the use of a new respiratory analeptic, doxapram (3,3-diphenyl-1-ethyl-4-(alpha-morpholinoethyl)-2-pyrrolidone chlorydrate) in the differential diagnosis and treatment of post-narcotic apnea].
Topics: Adult; Aged; Anesthesia; Apnea; Central Nervous System Stimulants; Doxapram; Humans; Middle Aged; Morpholines; Pyrrolidinones | 1967 |
[Doxapram. A respiration stimulator].
Topics: Apnea; Central Nervous System Stimulants; Doxapram; Humans; Morpholines; Postoperative Care; Pyrrolidinones; Respiration; Stimulation, Chemical | 1969 |
Recovery from central respiratory failure and administration of doxapram to a patient with a brainstem lesion.
Topics: Apnea; Brain Stem; Cerebrovascular Disorders; Coma; Doxapram; Female; Humans; Middle Aged; Quadriplegia; Respiratory Insufficiency | 1973 |
[Drug treatment of apnoea in premature infants (author's transl)].
Topics: Apnea; Chemoreceptor Cells; Doxapram; Humans; Infant, Newborn; Infant, Premature, Diseases; Neurotransmitter Agents; Phenobarbital; Sleep; Xanthines | 1981 |
Idiopathic apnoea of prematurity treated with doxapram and aminophylline.
Topics: Aminophylline; Apnea; Carbon Dioxide; Doxapram; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Time Factors | 1984 |
Doxapram and neonatal apnoea.
Topics: Apnea; Doxapram; Dyskinesia, Drug-Induced; Humans; Infant, Newborn | 1984 |
Doxapram in the treatment of idiopathic apnea of prematurity unresponsive to aminophylline.
Topics: Aminophylline; Apnea; Doxapram; Heart Rate; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases | 1984 |
Quantitation of doxapram in blood, plasma and urine.
Topics: Apnea; Doxapram; Flame Ionization; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Infant, Newborn; Infant, Premature, Diseases; Kinetics | 1980 |
Doxapram in tubeless anaesthesia for microlaryngeal surgery.
Topics: Anesthesia, Intravenous; Apnea; Doxapram; Humans; Intraoperative Complications; Intubation; Intubation, Intratracheal; Larynx; Microsurgery; Nasopharynx; Propofol | 1993 |
Second-degree atrioventricular heart block after doxapram administration.
Topics: Apnea; Doxapram; Female; Heart Block; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Respiratory System Agents | 1998 |
[Treatment of apnea in prematurity].
Topics: Apnea; Central Nervous System Stimulants; Doxapram; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intermittent Positive-Pressure Ventilation; Monitoring, Physiologic; Xanthines | 1998 |
Low-dose doxapram therapy for idiopathic apnea of prematurity.
Topics: Apnea; Doxapram; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Recurrence; Respiratory System Agents; Treatment Outcome; Xanthines | 2001 |
Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea.
Topics: Apnea; Case-Control Studies; Cerebral Hemorrhage; Child Development; Developmental Disabilities; Doxapram; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Respiratory System Agents; Retrospective Studies; Social Class; Time Factors; Treatment Outcome | 2001 |
[Determinants of doxapram utilization: a survey of practice in the French Neonatal and Intensive Care Units].
Topics: Apnea; Doxapram; France; Health Care Surveys; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Intensive Care Units, Neonatal; Practice Patterns, Physicians'; Respiratory System Agents | 2005 |
Brain hemodynamic effects of doxapram in preterm infants.
Topics: Apnea; Birth Weight; Blood Flow Velocity; Brain; Case-Control Studies; Doxapram; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Oxygen; Oxyhemoglobins; Prospective Studies; Respiratory System Agents; Retrospective Studies | 2006 |
Doxapram and hypokalaemia in very preterm infants.
Topics: Analysis of Variance; Apnea; Diuretics; Doxapram; Female; Furosemide; Humans; Hypokalemia; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Kaplan-Meier Estimate; Male; Potassium; Proportional Hazards Models; Respiratory System Agents; Retrospective Studies; Risk Factors | 2013 |
Amplitude-integrated electroencephalography shows that doxapram influences the brain activity of preterm infants.
Topics: Apnea; Brain; Doxapram; Electroencephalography; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Respiratory System Agents; Retrospective Studies | 2014 |
Long-Term Neurodevelopmental Outcome after Doxapram for Apnea of Prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Central Nervous System Stimulants; Child Development; Doxapram; Ductus Arteriosus, Patent; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Logistic Models; Male; Netherlands; Odds Ratio; Retrospective Studies; Treatment Outcome | 2016 |
Retrospective study shows that doxapram therapy avoided the need for endotracheal intubation in most premature neonates.
Topics: Apnea; Doxapram; Female; Humans; Infant, Newborn; Infant, Premature; Intubation, Intratracheal; Male; Respiratory System Agents; Retrospective Studies | 2017 |
Doxapram Treatment and Diaphragmatic Activity in Preterm Infants.
Topics: Apnea; Birth Weight; Diaphragm; Doxapram; Electromyography; Female; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Male; Netherlands; Pilot Projects; Prospective Studies; Respiratory System Agents | 2019 |
The Pharmacokinetics of Caffeine in Preterm Newborns: No Influence of Doxapram but Important Maturation with Age.
Topics: Apnea; Caffeine; Doxapram; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases | 2021 |